Clinical trials: Nonvalvular Atrial Fibrillation
Atrial Fibrillation
Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry
Brief Summary: A prospective, multicenter, single-arm, non-randomized study including consecutive patients with nonvalvular AF(Atrial Fibrillation), with a CHA2DS2-VASc score ≥2 (men) or ≥3 (women), and contraindication for…
- Trial name
- S-SAPT LAMBRE (NCT06620757)
- Testing
- Single antiplatelet therapy (SAPT)
- Where
- 22 sites in Spain
- Volunteers
- 234 people
- Sponsor
- Fundación EPIC
Atrial Fibrillation, Stroke
Stand-alone Left Atrial Appendage Occlusion for Thromboembolism Prevention
This prospective nationwide registry aims to assess the durability of left atrial appendage occlusion when performed via totally thoracoscopic, percutaneous and hybrid- minimally invasive approaches and collect information on…
- Trial name
- SALAMANDER (NCT05144958)
- Testing
- Totally thoracoscopic LAAO - ATRICLIP, Percutaneous LAAO - WATCHMAN, Hybrid- minimally invasive LAAO - LARIAT
- Where
- Poland
- Volunteers
- 400 people
- Sponsor
- Nicolaus Copernicus University